BioRestorative Therapies, Inc. financial data

Symbol
BRTX on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
40 Marcus Drive, Melville, NY
Fiscal year end
December 31
Former names
Stem Cell Assurance, Inc. (to 8/16/2011)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 355 % +82.8%
Debt-to-equity 35.2 % -61.3%
Return On Equity -85.2 % +44.5%
Return On Assets -63 % +21.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.92M shares +47%
Common Stock, Shares, Outstanding 6.92M shares +48.3%
Entity Public Float 13.7M USD +60.8%
Common Stock, Value, Issued 692 USD +47.9%
Weighted Average Number of Shares Outstanding, Basic 8.12M shares +77.7%
Weighted Average Number of Shares Outstanding, Diluted 8.12M shares -34.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 377K USD +190%
Research and Development Expense 4.76M USD +31.6%
General and Administrative Expense 7.68M USD -41.8%
Operating Income (Loss) -12.1M USD +27.6%
Nonoperating Income (Expense) 2.44M USD -81.8%
Net Income (Loss) Attributable to Parent -9.65M USD +16.6%
Earnings Per Share, Basic -1.07 USD/shares +64.7%
Earnings Per Share, Diluted -0.42 USD/shares +86.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.49M USD -38.9%
Marketable Securities, Current 11.6M USD +18.3%
Accounts Receivable, after Allowance for Credit Loss, Current 165K USD +320%
Assets, Current 13.5M USD +7.18%
Property, Plant and Equipment, Net 378K USD +23.5%
Operating Lease, Right-of-Use Asset 39.7K USD -74.3%
Intangible Assets, Net (Excluding Goodwill) 646K USD -12.2%
Assets 14.6M USD +5.6%
Accounts Payable, Current 401K USD +76.5%
Accrued Liabilities, Current 682K USD +24.3%
Liabilities, Current 4.58M USD +52.8%
Operating Lease, Liability, Noncurrent 42.4K USD -78.7%
Liabilities 4.58M USD +50.7%
Retained Earnings (Accumulated Deficit) -154M USD -6.68%
Stockholders' Equity Attributable to Parent 9.99M USD -7.15%
Liabilities and Equity 14.6M USD +5.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.32M USD +2.59%
Net Cash Provided by (Used in) Financing Activities 7.52M USD
Net Cash Provided by (Used in) Investing Activities -4.93M USD -294%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 6.92M shares +48.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 273K USD +70.6%
Deferred Tax Assets, Valuation Allowance 31.8M USD +14.6%
Deferred Tax Assets, Gross 32.1M USD +14.8%
Operating Lease, Liability 42.4K USD -78.7%
Payments to Acquire Property, Plant, and Equipment 60K USD -45.2%
Lessee, Operating Lease, Liability, to be Paid 43.3K USD -79.9%
Property, Plant and Equipment, Gross 1.37M USD +14.3%
Operating Lease, Liability, Current 42.4K USD -72.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 173K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 173K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 851 USD -94.8%
Deferred Tax Assets, Operating Loss Carryforwards 14.3M USD +8.42%
Preferred Stock, Shares Authorized 20M shares 0%
Operating Lease, Payments 43.3K USD +3%
Additional Paid in Capital 164M USD +5.72%
Amortization of Intangible Assets 22.4K USD +20.4%
Depreciation, Depletion and Amortization 39.4K USD +51.3%
Share-based Payment Arrangement, Expense 284K USD -81%
Interest Expense 28.8K USD -94.2%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%